-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Xinhua News Agency, Beijing, September 7 (Reporter Zhang Ying) Two preprinted research papers recently published by Israeli researchers show that the third dose of Pfizer's new crown vaccine can significantly reduce the risk of new crown virus infection
Israel began to carry out the new crown vaccine booster vaccination in phases from mid-July, mainly using Pfizer vaccine
The first study on the effect of the booster vaccine was completed by the Israeli Ministry of Health and the Israeli Weizmann Institute of Science and other research institutions
The second study is a collaboration between Israel Maccabi Healthcare Services Company and Yale University in the United States
Both of the above-mentioned preprinted papers have been published on the Medical Paper Archives website